Get the Stockscreener App
18.13
0.28%
-0.05
After Hours:
18.29
0.16
+0.88%
Progyny Inc stock is traded at $18.13, with a volume of 2.25M.
It is down -0.28% in the last 24 hours and down -13.58% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$18.18
Open:
$18.17
24h Volume:
2.25M
Relative Volume:
1.45
Market Cap:
$1.48B
Revenue:
$1.29B
Net Income/Loss:
$58.52M
P/E Ratio:
27.77
EPS:
0.6528
Net Cash Flow:
$191.78M
1W Performance:
+3.60%
1M Performance:
-13.58%
6M Performance:
-16.14%
1Y Performance:
-16.37%
1-Day Range:
$17.81
$18.29
1-Week Range:
$17.34
$18.30
52-Week Range:
$16.75
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
18.13 | 1.48B | 1.29B | 58.52M | 191.78M | 0.6528 |
UNH
Unitedhealth Group Inc
|
275.59 | 250.15B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
71.48 | 90.94B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
262.84 | 69.30B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
291.48 | 64.33B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
169.90 | 20.40B | 129.66B | 1.20B | 375.00M | 9.8083 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny CEO Details Utilization Trends, Forecasting and Progyny Select Fully Insured Rollout at Conference - MarketBeat
Why is Progyny Inc stock going downWeekly Trade Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Barclays Cuts Progyny (NASDAQ:PGNY) Price Target to $23.00 - MarketBeat
Barclays Lowers Price Target for Progyny (PGNY), Maintains Overw - GuruFocus
Progyny (PGNY) Chief Product Officer has RSU shares withheld for taxes - Stock Titan
Barclays cuts Progyny stock price target on membership concerns By Investing.com - Investing.com Canada
Barclays cuts Progyny stock price target on membership concerns - Investing.com
Recap Report: What analysts say about Progyny Inc stock2026 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn
Assessing Progyny (PGNY) Valuation After Prolonged Share Price Weakness - simplywall.st
Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny at KeyBanc Forum: Strategic Growth and Challenges By Investing.com - Investing.com India
Progyny at KeyBanc Forum: Strategic Growth and Challenges - Investing.com
Targets Report: Is Progyny Inc attractive for institutional investors2026 EndofMonth & Daily Stock Trend Reports - baoquankhu1.vn
Progyny, Inc. $PGNY Shares Purchased by Algert Global LLC - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Sees Significant Growth in Short Interest - MarketBeat
Progyny Announces Settlement, Governance Reforms on Director Pay - The Globe and Mail
Is Progyny (PGNY) Pricing Reflect Its Steep Multi‑Year Share Price Declines Today - simplywall.st
Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook - AOL.com
Assessing Progyny (PGNY) Valuation After Recent Share Price Weakness - Yahoo Finance
Progyny Inc. Announces Notice of Pendency of Settlement of Derivative Action – Corporate Information and SEC Filing Details - Minichart
(PGNY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Progyny issues notice of settlement for derivative action regarding director pay - Investing.com
Progyny Issues Notice Of Pendency Of Settlement Of Derivative Action - TradingView
Progyny agrees to settle derivative suit, adopts new director pay limits and governance reforms - TradingView
Proposed Progyny (NASDAQ: PGNY) director pay settlement adds governance reforms - Stock Titan
Progyny (PGNY) Receives a Hold from Canaccord Genuity - The Globe and Mail
Progyny at Barclays Healthcare Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Canaccord Genuity Group Lowers Progyny (NASDAQ:PGNY) Price Target to $19.00 - MarketBeat
Canaccord lowers Progyny stock price target on covered lives concerns By Investing.com - Investing.com Canada
Progyny’s Dual Use of Buybacks and ESOP Shares Raises a Key Capital Allocation Question (PGNY) - simplywall.st
Barclays PLC Purchases 696,447 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny at Leerink Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa
Progyny at Leerink Conference: Strategic Expansion in Healthcare - Investing.com
Quantbot Technologies Reduces Stake in Progyny - National Today
Quantbot Technologies LP Reduces Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. $PGNY Shares Bought by Dynamic Technology Lab Private Ltd - MarketBeat
Progyny, Inc. Hits New 52-Week Low at $16.75 Amid Declining Performance - Markets Mojo
PGNY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
US Stocks Recap: Is Progyny Inc a good ESG investmentMarket Trend Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Progyny (PGNY) Receives a Buy from Truist Financial - The Globe and Mail
Progyny's Valuation Upgrade Reflects Improved Financial Metrics Amid Market Dynamics - Markets Mojo
Will Progyny Inc. stock deliver strong dividend growthPortfolio Value Report & Reliable Breakout Stock Forecasts - Naître et grandir
Jefferies Maintains Buy on PGNY (Progyny, Inc.) March 2026 - Meyka
Progyny (PGNY) EVP GC sells shares under 10b5-1 plan, pays tax - Stock Titan
Progyny (PGNY) CFO reports 339-share tax-withholding disposition on Form 4 - Stock Titan
Jefferies cuts Progyny stock price target on guidance miss By Investing.com - Investing.com Australia
Jefferies cuts Progyny stock price target on guidance miss - Investing.com India
Progyny, Inc. Leadership to Participate in Key Investor Conferences in March 2026 - Quiver Quantitative
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences - GlobeNewswire
Progyny leaders hit March healthcare stages on fertility tech - Stock Titan
BTIG Research Lowers Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.52%
2.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):